Company intelligence / Profile preview

Atalaya Capital Management

New York, New York, USAatalayamining.com ↗

Ownership: Private
Development stage: Other

Overview

Atalaya, most commonly referring to Atalaya Capital Management, is an alternative investment advisory firm founded in 2006 and headquartered in New York City. It manages over $10 billion USD primarily through private credit and special opportunities strategies spanning corporate debt/equity investments—including some exposure to healthcare/life sciences via its portfolio—but it does NOT itself develop drugs or medical technologies nor operate as a biotech/pharma/CRO/CMO company. In September 2024 it was acquired by Blue Owl Capital. The only direct connection to health/life sciences comes from its role as an investor or lender into relevant operating companies such as CipherHealth.

Industry: Investors

Partnerships

Invests in various companiesCipherHealth

Beyond the preview

Go deeper on Atalaya Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atalaya Capital Management.

Explore the full profile